We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Nixes Two Gilead HIV Drugs As Standalone Treatments in CRL
FDA Nixes Two Gilead HIV Drugs As Standalone Treatments in CRL
May 3, 2013
Gilead’s efforts to win approval of two HIV medications — already marketed as part of its quad combo Stribild — came to a halt April 29.